insights_auto
Why is TMCI down ३.९७%?
Dive Deeperchevron_right
TMCI:NASDAQ
Treace Medical Concepts, Inc
US$ ४.३५
arrow_downward
-३.९७%(-०.१८) 1D
नोभेम्बर १९, १६:००:०१ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
US$ ४.५६
High
US$ ४.८८
Low
US$ ४.३४
Mkt. cap
२८.५२ करोड
Avg. vol.
२.९१ लाख
Volume
०.००
52-wk high
US$ ५.४३
52-wk low
US$ १.१७
EPS
-US$ ०.८६
Beta
१.५९
Shares outstanding
६.५६ करोड
No. of employees
४५०
Open
US$ ४.५६
High
US$ ४.८८
Low
US$ ४.३४
Mkt. cap
२८.५२ करोड
Avg. vol.
२.९१ लाख
Volume
०.००
52-wk high
US$ ५.४३
52-wk low
US$ १.१७
EPS
-US$ ०.८६
Beta
१.५९
Shares outstanding
६.५६ करोड
No. of employees
४५०
News stories
From web sources and news partners
TradingView
·
१ घण्टा पहिले
Stock Market: Will S&P 500 Open Up or Down Today?
FOREX.com
·
२ घण्टा पहिले
S&P 500 Analysis: SPX Is Going Through One of Its Most Difficult Periods of 2026
Adam Feldman | Substack
·
१३ घण्टा पहिले
Inside the Federal Litigation of Five S&P 500 Giants
BigGo Finance
·
७ घण्टा पहिले
Chip ETF Eyes Unprecedented Fourth Straight Year of Beating the S&P 500
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc